miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1

Japanese Journal of Clinical Oncology

Volumn 45, Issue 5, 2015, Pages 474-482

  Sun, Xianglun ^a   Li, Youkong ^b   Yu, Jie ^b   Pei, Hong ^b   Luo, Pengcheng ^c   Zhang, Jie ^a,c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUBEI POLYTECHNIC UNIVERSITY   (China)

Author keywords

Chemosensitivity; Invasion; miR 128; ZEB1

Indexed keywords

CISPLATIN; MICRORNA; MICRORNA 128; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; COLORING AGENT; HOMEODOMAIN PROTEIN; MIRN128 MICRORNA, HUMAN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN; ZINC FINGER PROTEIN;

ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LNCAP CELL LINE; MALE; MTT ASSAY; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING; DISEASE COURSE; DOWN REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; METABOLISM; PATHOLOGY; PROSTATIC NEOPLASMS; TISSUE CULTURE TECHNIQUE;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; COLORING AGENTS; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOPRECIPITATION; MALE; MICRORNAS; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAZOLIUM SALTS; THIAZOLES; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION FACTORS; ZINC FINGERS;

EID: 84930006512     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyv027     Document Type: Article

References (36)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CACancer J Clin 2013;63:11-30.
2. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-5.
3. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33.
4. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011;223:102-15.
5. Chen Q, Zhao X, Zhang H, et al. MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2. Mol Carcinog 2014; doi: 10.1002/mc.22204.
6. Liu C, Kelnar K, Liu B, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011;17:211-5.
7. Singh S, Chitkara D, Mehrazin R, Behrman SW, Wake RW, Mahato RI. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway. PLoS One 2012;7:e40021.
8. Li F, Mahato RI. MicroRNAs and drug resistance in prostate cancers. Mol Pharm 2014;11:2539-52.
9. Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, White RW. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 2011;71:538-49.
10. Ma S, Chan YP, Kwan PS, et al. MicroRNA-616 induces androgenindependent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Cancer Res 2011;71: 583-92.
11. Liu Y, Peng X, Tan J, Darling DS, Kaplan HJ, Dean DC. Zeb1 mutant mice as a model of posterior corneal dystrophy. Investig Ophthalmol Vis Sci 2008;49:1843-9.
12. Bronsert P, Kohler I, Timme S, et al. Prognostic significance of zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancerassociated fibroblasts in pancreatic head cancer. Surgery 2014;156: 97-108.
13. Denecker G, Vandamme N, Akay O, et al. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression. Cell Death Differ 2014;21:1250-61.
14. Romero-Perez L, Lopez-Garcia MA, Diaz-Martin J, et al. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma. Mod Pathol 2013;26:1514-24.
15. Sreekumar R, Mirnezami A, Wilson H, et al. Zinc finger e-box binding homeobox 1 (ZEB1) induces epithelial to mesenchymal transition (EMT) and promotes tumour progression in hepatocellular carcinoma (HCC). Gut 2012;61:A127-8.
16. Bai WD, Ye XM, Zhang MY, et al. MiR-200c suppresses TGF-beta signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Int J Cancer 2014;135: 1356-68.
17. Yu J, Lu Y, Cui D, et al. miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1. Oncol Rep 2014;31:910-8.
18. HuangWT, Kuo SH, Cheng AL, Lin CW. Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior. Mod Pathol 2014;27: 1116-25.
19. Hao J, Madigan MC, Khatri A, et al. In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147. PLoS ONE 2012;7:e40716.
20. Jin M, Zhang T, Liu C, et al. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res 2014;74: 4183-95.
21. Reis ST, Pontes-Junior J, Antunes AA, et al. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol 2012;12:14.
22. Sun T, Wang X, He HH, et al. MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A. Oncogene 2014;33:2790-800.
23. Wei W, Yuasa T, Tsuchiya N, et al. A mutant allele in a miR-181 bindingsite of the MeL-18 gene is associated with a poor prognosis in prostate cancer. J Urol 2008;179:104-104.
24. Corcoran C, Rani S, O'Driscoll L. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Prostate 2014;74:1320-34.
25. Kang S, Zhao Y, Hu K, et al. miR-124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathway. Prostate 2014;74:1095-106.
26. Zeng Y. Regulation of the mammalian nervous system by MicroRNAs. Mol Pharmacol 2009;75:259-64.
27. Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, et al. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene 2012;31:1884-95.
28. Huang W, Feng Y, Liang J, et al. Mir-128 targets E2f3 to regulate cardiomyocyte cell cycle re-entry. Circulation 2013;128(Suppl 22):A10616.
29. Adlakha YK, Saini N. MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells. Cell Mol Life Sci 2011;68:1415-28.
30. Khan AP, Poisson LM, Bhat VB, et al. Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer. Mol Cell Proteomics 2010;9:298-312.
31. Li P, Wang J, Chu M, Zhang K, Yang R, Gao WQ. Zeb1 promotes androgen independence of prostate cancer via induction of stem cell-like properties. Exp Biol Med 2014;239:813-22.
32. Yang Y, Ahn YH, Chen Y, et al. ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3 K antagonism. J Clin Investig 2014;124: 2696-708.
33. Dou J, He X, Liu Y, et al. Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs. Cell Biol Int 2014;38:452-61.
34. Guo F, Cogdell D, Hu L, et al. miR-101 suppresses the epithelial-tomesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma. Oncol Rep 2014;31:2021-8.
35. Wang Y, Yan S, Liu X, et al. miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma. Oncol Rep 2014;31:1905-10.
36. Nanta R, Kumar D, Meeker D, et al. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2R[gamma] null mice by regulating Bmi-1 and microRNA-128. Oncogenesis 2013;2:e42.